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Sillnl'nary 
GL183 or EB6 (p58) molecules have been shown to function as receptors for different HLA-C 
alleles and to deliver an inhibitory signal to natural killer (NK) cells, thus preventing lysis of 
target cells. In this study, we analyzed a subset of NK cells characterized by a p58-negative surface 
phenotype. We show that p58-negative clones,  although specific for class I molecules do not 
recognize HLA-C alleles. In addition, by the use of appropriate target cells transfected  with 
different HLA-class  I alleles we identified HLA-B7 as the protective element recognized by a 
fraction of p58-negative clones. In an attempt to identify the receptor molecules expressed by 
HLA-B7-spedfic clones, monodonal antibodies (mAbs) were selected after mice immunization 
with such clones. Two of these mAbs, termed XA-88 and XA-185, and their F(ab')2 fragments, 
were found to reconstitute lysis of B7 + target cells by BT-specific NK clones. Both mAbs were 
shown to be directed against the recently clustered Kp43 molecule (CD94). Thus, mAb-mediated 
masking of Kp43 molecules interferes  with recognition of HLA-B7 and results  in target cell 
lysis. Moreover,  in a redirected killing assay, the cross-linking of Kp43 molecules mediated by 
the XA185 mAb strongly inhibited the cytolytic activity of HLA-B7-specific NK clones, thus 
mimicking the functional effect of B7 molecules. Taken together, these data strongly suggest 
that Kp43 molecules function as receptors for HLA-B7 and that this receptor/ligand interaction 
results  in inhibition of the NK-mediated cytolytic activity.  Indirect immunofluorescence and 
FACS  |  analysis of a large number of random NK clones showed that Kp43 molecules (a) were 
brightly expressed on a subset of p58-negative clones, corresponding to those specific for HLA- 
B7; (b) displayed a medium/low fluorescence in the p58-negative clones that are not B7-specific 
as well as in most p58 + NK clones; and (c) were brightly expressed as in the p58 + clone ET34 
(GL183-/EB6 +,  Cw4-specific).  Functional  analysis  revealed  that  Kp43  functioned  as  an 
inhibitory receptor only in NK clones displaying bright fluorescence. These studies also indicate 
that some NK clones (e.g.,  the ET34) can coexpress two distinct receptors (p58 and Kp43) for 
different class I alleles (Cw4 and B7). Finally, we show that Kp43 molecules function as receptors 
only for some HLA-B alleles and that still undefined receptor(s)  must exist for other HLA-B 
alleles including B27. 
N 
'K cells represent a lymphoid population that does not 
express TCRs or surface immunoglobulins  and is charac- 
terized by the CD3-CD16+CD56 + surface phenotype and 
by the ability to lyse some tumor or virally infected cells (1). 
Clonal analysis of human NK cells allowed to demonstrate 
a clonal heterogeneity in the ability to lyse different target 
cells (2-4). The molecular mechanisms involved in the sus- 
ceptibility/resistance to lysis of target ceils to some NK clones 
has recently been clarified (5-10).  Thus, whereas the surface 
receptors and target molecules that are physiologicaUy  involved 
in NK cell triggering and target cell lysis are only partially 
understood (11-13), it has been established  that the surface 
expression of given HLA-C alleles protects target cells from 
lysis mediated by two distinct subsets of NK clones (14, 15). 
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groups of HLA-C alleles (represented by Cwl, Cw3, Cw7, 
Cw11, and by Cw2, Cw4, Cw5, and Cw6, respectively) (16, 
17) is mediated by clonally distributed specific receptors that 
have been recently identified and analyzed in detail. These 
receptors  belong to a new family of NK-specific  p58 mole- 
cules (18, 19) that after interaction with target cells expressing 
the appropriate HLA-C alleles, deliver a "negative signal" 
resulting in inhibition of NK cell-mediated cytotoxicity and 
thus in target cell protection. This negative signal can be 
blocked by appropriate anti-p58 or anti-dass I mAbs (15, 20). 
As a consequence, HLA-C-protected target cells became sus- 
ceptible to lysis by NK clones specific  for the protective HLA-C 
allele (15, 20).  However, a fraction of NK cells, variable in 
size in different individuals, do not express p58  molecules 
(as detected by the GL183  and EB6 mAbs) (19) and thus, 
it is likely that they do not recognize HLA-C molecules. 
In this study, we identified a subset of GL183-/EB6- 
(p58-negative)  clones (19) that are not specific for HLA-C 
molecules but rather recognize certain HLA-B alleles. Per- 
haps more importantly, we provide suggestive evidence that, 
in these clones, the surface molecule acting as putative receptor 
for HLA-B is represented by the Kp43 (CD94) molecule (21, 
22).  Finally,  we show that, in individual clones,  both p58 
and Kp43 molecules may be involved in the delivery of a nega- 
tive signal, thus providing direct evidence for the existence 
of NK clones with dual specificity. 
Materials  and Methods 
Antibodies.  MAbs OKT3  (IgG2a anti-CD3;  Ortho  Phar- 
maceuticals, Raritan, NJ), JT3A (IgG2a anti-CD3), HP2.6 (IgG2a 
anti-CD4), B9.4 (IgG2b anti-CD8), GL183 (IgG1 anti-p58), EB6 
(IgG1 anti-p58), XA-141 (IgM anti-p58), KD1 (IgG2a anti-CD16), 
c127 (IgG1 anti-CD16), c288 (IgG1 anti-CD16), K218 (IgG1 anti- 
CD56), A6-220 (IgM anti-CD56), and A6-136 (IgM anti-HLA 
class I) (20) were used in this study. 
Cloning of CD3-I6+56 + Lymphocytes.  PBLs derived from 
normal donors were isolated on Ficoll-Hypaque  gradients and cells 
were then incubated with a mixture of OKT3, HP2.6, and B9.4 
mAbs followed by treatment with rabbit complement for 1 h at 
37~  as previously  described (2, 18). Viable  cells were isolated and 
cloned under limiting dilution conditions in the presence of  irradi- 
ated feeder ceils 0.1% (vol/vol) PHA (Gibco Ltd., Paisley, Scot- 
land)  and  exogenous IL-2 (recombinant-Ib2;  Cetus  Corp., 
Emeryville, CA) as previously described for both T and NK cell 
cloning (2, 23, 24). 
Cytolytic Assays.  The cytolytic activity of cloned NK cells was 
assessed in a 4-h 5'Cr-release assay in which effector cells were 
tested against the murine P815 cell line (either transfected with 
the Cw3 gene or untransfected) (14) or the C1R human cell line 
(8, 15) transfected or not with various HLA class I genes (kindly 
provided by B. Biddison, National Institutes of Health, Bethesda, 
MD; J. A. Lopez De Castro, Fundacion Yimenez Diaz, Madrid, 
Spain; and P. CressweU, Yale University, New Haven, CT). Other 
target cells used in these studies were represented by a B-EBV cell 
line termed 81 and by a cell variant (81.OA) that lacks the expres- 
sion of HLA-dass  I (14). We also used a homozygous  cell  line termed 
R6/12367, kindly provided by Dr. F. Christiansen (Royal Perth 
Hospital, Perth, Australia) (17) and a B-EBV cell line derived from 
donor E. C. 
All these target cells were used at 5  x  103/well and the final 
E/T ratio is indicated in the text. Percent specific lysis was deter- 
mined as previously described (2). mAbs were added at the onset 
of the cytolytic assay  before adding target cells. The mAb concen- 
trations used in the various assays are indicated in the text. 
Flow Cytofluorimetric  Analysis.  Cells  were stained with the ap- 
propriate mAb followed  by fluoresceinated  goat anti-mouse Ig. Con- 
trol aliquots were stained with the fluoresceinated  reagent alone. 
All samples were then analyzed on a flow cytometer (FACStar| 
Becton Dickinson & Co., Mountain View, CA) gated to exclude 
nonviable calls (3). 
Preparation of F(al/)2 Fragments.  This method was previously 
described (19). Briefly 2 ml of DEAE-Sephacel (Pharmacia LKB 
Biotechnology, Uppsala, Sweden)-purified  mAb (1 mg/ml) were 
dialyzed overnight against acetate buffer (0.1 M, pH 3.8). Next, 
the mAb was digested with 50 gg of pepsin (Worthington Bio- 
chemical Corp., Freehold, NJ) for 6 h at 37~  after which the 
digestion was stopped with 3 M Tris-HCl, pH 8.6, and by placing 
the reaction mixture on ice. This mixture was dialyzed overnight 
50 mM Tris-HC1, pH 8, and applied to a 10-ml DEAE-Sephacel 
column. 1-ml fractions were collected and assayed spectrophoto- 
metrically at 280 nm and by 7 and 11% SDS-PAGE  under reducing 
and nonreducing conditions, respectively. 
Production of mAh  5-wk-old male BALB/c mice were im- 
munized with  a cell done termed  SE192 (surface phenotype: 
CD3- CD16 +  CD56 §  GL183-/EB6-)  as previously  described (18). 
The immunization schedule consisted of 2-wk intravenous injec- 
tions of 107 SE192 cells. After six injections, the mice were sple- 
nectomized and immune splenocytes  were fused with P3U1 my- 
eloma cells (18). The screening  of  hybridoma  supernatants  was based 
on the ability to reconstitute the cytolytic function of SE192 calls 
against B7 protected target cells. To this end, 25  x  103 SE192 cells 
were cultured  together  with 5  x  103  target  cells (for a final 
effector/target ratio of 5:1) in the presence of 50 #1 of culture su- 
pernatants derived  from the various hybridomas.  The assay  was per- 
formed in V-bottomed microtiter trays in a final volume of 200 
#1. After 4 h, 100 #1 of supernatant was removed from each well 
and counted in a gamma counter for the assessment of 5'Cr re- 
lease. Percent specific  target cell lysis  was determined as previously 
described (23). According  to this screening  procedure, two hybrid- 
omas, termed XA88 and XA185, able to reconstitute the cytolytic 
activity of SE192 done were isolated and further subdoned in lim- 
iting dilution. 
Results 
Identification of GL183-/EB6-  NK Clones That Recognize 
HLA-class I Molecules Different from HLA-C.  A series of NK 
clones derived from donor E. C. (HLA haplotype: A1, A3; 
B14,  B27;  Cw2,  C-)  (19) and  characterized  by  the 
GL183-/EB6-  (p58-negative)  phenotype were assessed for 
cytolytic activity against the 81 target cell, a previously de- 
scribed B-EBV-transformed  cell line heterozygous for all three 
class I loci (14). A large fraction (90%) of the 30 representa- 
tive p58-negative clones,  shown in Fig.  1,  were unable to 
kill the 81 target cells. However, the same group of clones 
killed efficiently  the 81-OA cell variant, characterized by the 
loss of expression of all class I alleles (14). That indeed HLA- 
class I molecules represented the protective elements of the 
81 cell line was confirmed by the finding that addition of 
the anticlass  I mAb A6-136  (IgM) (20) could restore lysis 
of the 81 target cells (by the same clones).  Since the 81 cells 
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Figure  1.  GL183-/EB6-  (p58-negative) NK clones recognize and are 
inhibited by HLA-class I molecules. A  shows the cytolytic activity of 30 
representative clones derived from donor E. C. against the 81 cell line (14) 
at an effector/target  ratio of 10:1. In B, the same clones were tested against 
the 81OA,  a class I negative variant  of the 81 cell line. In C, the same 
clones were analyzed against the 81 cell line in the presence of an appro- 
priate  anticlass I mAb (A6-136 of IgM isotype)  (20). 
are Cw3 §  +,  we asked whether p58-negative clones, 
similar to those expressing p58 molecules (15), could recog- 
nize HLA-C molecules. To this end, three representative p58- 
negative clones (SE184, SE192, and SE276),  which did not 
lyse 81 cells, were analyzed for their ability to lyse target cells 
expressing either Cw3 or Cw4 alleles. The first target was 
represented by the murine P815 cell line transfected with Cw3 
(14,  15) and the second by the Cw4 + B-EBV cell line C1R 
(8,  15). These target cells had been shown (15) to be pro- 
tected from lysis by GL183 +/EB6 + clones (group 2, Cw3- 
specific) or GL183-/EB6 + clones (group 1, Cw4-specific), 
respectively. Since both target cells were not protected against 
the lysis mediated by clones SE184,  SE192,  and SE276,  it 
was concluded that the elements conferring protection to 81 
target cells were represented by class I molecules different from 
HLA-C. Five additional clones, isolated from the same donor, 
were analyzed for comparison: three clones (ET34, SE456, 
and SE273) displayed the EB6 +/GL183-  phenotype and be- 
longed to group 1 clones, specific for the Cw4 allele (3, 15). 
These group  1 clones displayed a strong cytolytic activity 
against  the  81-OA  variant  but  they  did  not kill  the 
(Cw3+/Cw4 *) 81 cell line.  As expected (15),  when ana- 
lyzed against either the Cw4 § CIR cell line or the Cw3 § 
P815  transfectants,  only the Cw4 §  cell line was resistant 
to lysis  (Table  1).  One  clone  (SE362)  displayed  the 
GL183 +/EB6 ~ phenotype and belonged to group 2 clones 
specific for the Cw3 allele (3,  14,  15).  Thus,  SE362  clone 
did not  kill  the 81  cell line (Cw3 +/Cw4 +)  (14) nor the 
Cw3 + transfectant of the P815  cell line (15). Finally,  we 
analyzed the SE200 done, representative of the three p58-neg- 
ative clones shown in Fig.  1,  that  efficiently lysed the 81 
cell line.  The  ability  to  lyse  81  cdls  would  indicate that 
done SE200 does not recognize protective dements expressed 
by these cells. As expected, the SE200 done lysed both CIR 
and the Cw3-transfected P815  cdls.  Taken together,  these 
data suggest that a fraction of p58-negative clones derived 
Table  1.  P58-negative NK Clones Do Not Recognize the 
HLA-C Alleles Expressed by the 8I  Cell Line 
Target cells* 
p58  CIR  P815 
Clone*  Phenotype  81EBV 81OA  (CW4 §  (Cw3 +) 
SE192  GL183-/EB6-  4  73  81  72 
SE276  GL183 -/EB6-  2  70  76  66 
SE184  GL183-/EB6-  7  84  92  76 
SE200  GL183-/EB6-  62  65  68  60 
SE456  GL183-/EB6 +  4  81  6  73 
SE273  GL183-/EB6 §  4  64  2  61 
ET34  GL183-/EB6 +  6  91  9  84 
SE362  GL183§  +  5  72  ND  3 
* All clones represented  in this table were derived  from donor E. C. 
* Results are expressed as a percent  specific SlCr-release at an E/T ratio 
of 10:1 (see Materials and Methods).  Note that, as previously  reported 
(14,  see also in the text) the 81 cell line is Cw3+/Cw4 + whereas  the 
81OA cell variant  is HLA-class  I negative.  The C1R cell line express 
Cw4 as the only detectable class I allele (8). The P815 used in these ex- 
periments  has been  transfected  with the HLA-Cw3 gene. 
from donor E. C. recognizes class I molecules different from 
HLA-C. 
A  Subset ofp58-negative Clones Recognize HLA-B Alleles.  In 
an attempt to better define the class I specifidty of p58-negative 
clones, we analyzed, as target cells, the homozygous cell line 
R6/12367 (17) displaying the HLA A3, B7, Cw7 haplotype. 
Also these target cells were not lysed by the p58-negative 
clones SE184, SE192, and SE276. Since CIR cells transfected 
with A3 and B7 alleles were available, we could further in- 
vestigate the susceptibility to lysis of these cell transfectants. 
As shown in Table 2,  CIR cells transfected with A3 were 
Table  2.  Some  P58-negative NK Clones Recognize HLA-B7 
Target cells* 
p58  CIR  CIR  CIR 
Clone*  Phenotype  R6/12367  CIR  A3 +  B27 §  B7 + 
SE192  GL183-/EB6-  8  81  78  80  11 
SE276  GL183-/EB6-  4  73  72  71  6 
SE184  GL183-/EB6-  9  93  85  88  10 
SE200  GL183-/EB6-  62  75  71  72  74 
SE456  GL183-/EB6 +  83  6  ND  6  8 
SE273  GL183-/EB6 §  71  4  ND  3  3 
* All clones represented  in the table were derived  from donor E. C. 
Results are expressed as a percent  specific SlCr-release at an E/T ratio 
of 10:1 (see Materials and Methods).  Note that the R6/12367 cell line, 
as previously  reported (17) is homozygous for all class I loci (A3, BT, 
Cw7). The C1R cell line (Cw4 +) was used either untransfected or trans- 
fected  different  class I alleles. 
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Figure 2.  Anticlass I mAb reconstitute  the cytolytic 
activity of HLA-B7-specific  p58-negative  clones against 
HLA-B7-protected  target cells. Three  representative  clones 
(SE-184. SE-192, SE-276), which do not lyse the B7- 
protected  target  cells  R6/12367 or CIR/B7 and the SE200 
clone, were tested at an E/T ratio of 10:1 either in the 
presence  or in the absence of the anticlass I A6-136 mAb 
(20). Cytolytic  activity  against R.6/12367 target cells in 
the absence [] or in the presence ￿9  of mAb. Cytolytic 
activity  against CIR/B7 target cells in the absence [] or 
in the presence [] of A6-136 mAb. 
lysed, whereas C1R cells transfected with B7 (C1R/B7) were 
resistant to lysis. These data indicate that the protective ele- 
ment expressed by the R6/12367 cell line is represented by 
the B7 allele. Moreover, reconstitution of lysis of CIR/B7 
or R6/12367 target cells was induced by the addition of the 
anti-HLA class I mAb A6-136 of IgM isotype (20) (Fig. 2). 
In addition, it is of note that C1R cells transfected with HLA- 
B27 (not expressed by the R6/12367 cells) were susceptible 
to lysis by B7-specific  clones. 
Selection of mAbs Able to Reconstitute the Cytolytic Activity 
of p58-negative NK Clones against HLA-B7-protected  Target 
Cells.  In an attempt to identify the surface receptor involved 
in the recognition of the B7 allele by p58-negative clones, 
we immunized mice with NK dones displaying this specificity. 
After cell fusion, the hybridoma supernatants were screened 
for the ability to reconstitute lysis of B7-protected target cells 
(R6/12367) by the NK clone SE192. Two mAbs displaying 
this functional property were isolated (the IgG1 XA-185 and 
the IgG3 XA-88). Both mAbs were found to immunopre- 
cipitate ,~70-kD molecules under nonreducing conditions and 
43-kD molecules under reducing conditions. The compara- 
tive analysis of the cellular distribution and of the biochem- 
ical properties of the immunoprecipitated molecules indicated 
that both mAbs were directed to the previously defned Kp43 
molecules recognized by the HP-3B1 mAb (21, 22). Indeed, 
both the XA-185 and HP-3B1 mAbs were recently clustered 
as CD94 (25) (Sth International Conference on Human Leu- 
kocyte Differentiation Antigens,  1993,  Boston,  MA). 
As shown in Fig. 3 A, mAb concentrations of'v1-5/~g/ml 
efficiently reconstituted the lysis of B7-protected target cells 
(R6/12364 cells) by clone SE192. Interestingly, these mAb 
concentrations were similar to those required with anti-p58 
mAbs to reconstitute lysis of HLA-C-protected target cells 
by p58-positive NK clones (15). In addition, reconstitution 
of target cell lysis by p58-negative clones was induced by both 
anti-Kp43 mAbs and their F(ab')z fragments (Fig.  3, A  and 
B).  As shown in Fig. 3 B,  these data were comparable to 
the three p58-negative dones analyzed. This figure also shows, 
for comparison, the reconstitution of lysis of the R6/12367 
cell line (Cw7 +) by a group 2 GL183 +/EB6 + clone medi- 
ated by anti-p58  mAbs.  Although not shown,  anti-Kp43 
mAbs were able to reconstitute the lysis of CIR/B7 target 
cells by the B7-specific  p58-negative clones SE184,  SE192, 
and SE276.  Remarkably, all these clones also failed to lyse 
CIR cells transfected with HLA-B14 or HLA-B8 (not shown) 
while they killed the C1R/B27  cells (Table 2).  These data 
indicate that B14 and B8 (but not B27) alleles display a pro- 
tective effect similar to B7. 
Anti-Kp43  mAbs Reconstitute the Lysis of Autologous Target 
Cells  by HLA-BT-specific  p58-negative NK  Clones.  Since 
SE192, SE184,  and SE276 clones were derived from donor 
E. C. (HLA-B14 +) (19) and an EBV cell line was available 
from this donor, we assessed whether the XA-185 and XA- 
88 mAbs could induce these clones to lyse autologous target 
cells. As shown in Fig. 4, autologous B-EBV cells, normally 
resistant to lysis by self NK clones (20), were efficiently killed 
in the presence of anti-Kp43 mAbs. These data indicate that 
Kp43 molecules are involved in the recognition of self-dass 
I molecules and in the mechanism of protection of autolo- 
gous target cells from NK cell-mediated lysis. In this con- 
text, previous data indicated that the anti-Kp43 mAb HP3B1 
could induce (at least in some donors) lysis of autologous 
PHA blasts by polyclonal NK cell populations (22).  On the 
basis of our present results, the above data can be interpreted 
as an inhibition of self-MHC recognition rather than an ac- 
tivation of the cytolytic activity mediated by anti-Kp43 mAbs. 
(Fig.  4  also  shows,  for  comparison,  two  representative 
GL183-/EB6 + clones (SE456 and SE273) derived from the 
same donor and belonging to group 1 (Cw2-specific) (3, 16, 
17). In this case, lysis of autologous target cells was detected 
in the presence of anti-p58 (EB6 or XA141 mAb) but not 
of anti-Kp43 mAbs (15). It is noteworthy that also these clones 
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Figure 3.  Anti-Kp43 mAbs reconstitute the cytolytic activity of HLA- 
B7-specific p58-negative clones against HLA-B7-protected target cells. In 
expressed surface Kp43 molecules (in medium/low amounts) 
(see below). Finally, clone SE200 did not kill autologous B- 
EBV cells and the protective effect could be reverted by the 
antidass I mAb A6-136 but not by anti-Kp43  mAbs (not 
shown). 
Anti-Kp43  mAbs Inhibit the NK-mediated Cytolysis of FcTR + 
Target Cells.  As previously shown, in redirected killing assays 
(i.e., using FcTR + targets),  addition of anti-p58  mAbs in- 
hibited the lysis of murine unprotected (HLA-negative) P815 
target cells. Thus, the mAb-mediated cross-linking  of p58 
molecules  mimicks the  effect of HLA-C  molecules  (15). 
Previous data also indicated that the anti-Kp43 mAb HP-3B1 
inhibited the lysis of P815 target cells mediated by polyclonally 
activated NK cell populations (22). Therefore, we analyzed 
whether anti-Kp43  mAbs had a similar effect on the cyto- 
lytic activity of clones SE184, SE192, and SE276 against the 
FcyR + P815 target cells. As shown in Fig. 5, lysis of P815 
target cells by clones SE192 and SE184 was strongly inhibited 
by both XA-185 and XA-88 mAbs. In addition, both mAbs 
strongly inhibited the cytolytic activity induced by anti-CD16 
mAbs (not shown). On the basis of these results, it appears 
that the functional effect of Kp43 molecules, at least in the 
p58-negative clones analyzed, is comparable to that of P58 
molecules in P58 + clones (15, 18, 19). Accordingly, the in- 
hibitory activity detected in redirected killing assays may be 
interpreted as the ability of anti-Kp43  mAb to mimick the 
interaction of Kp43 molecules with class I molecules expressed 
by "protected" target cells (15). The F(ab')2 fragments of 
anti-Kp43 mAbs did not inhibit the lysis of P815 cells. This 
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(left) or of the F(ab)2 fragment of XA-185 (A) mAb (right)  is shown. 
Effector cells are represented by the p58-negative NK clone SE-192 and 
target cells by the HLA-B7 + cell line R6/12367.  In B, three representa- 
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Figure 4.  EBV-transformed cells are lysed by autolo- 
gous NK clones in the presence of the appropriate an- 
tireceptor mAb. A B-EBV cell line derived from donor 
E. C. (HLA-B14  +) was used as target cell in a cytolytic 
assay in which autologous NK clones displaying different 
specificities were tested either in the presence or in the 
absence  of the following mAbs: the anti-KF43 mAbs XA- 
185  (.)  or XA-88  (0)  and the anti-p58  mAbs EB6 
(asterisk) or XA-141 (+) both directed to the same p58 
molecule (EB6). 
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Figure  5.  Anti-Kp43 mAbs inhibit the cytolytic activity mediated by 
HLA B7-specific p58-negative clones in a redirected killing assay. Clones 
SE-192 and SE-184 were tested for cytolytic activity against the unprotected 
(murine) Fcq,  R + P815 target cells in the absence or in the presence of 
anti-Kp43 mAbs (e XA185 mAb; O  XA-185 F(ab')2; ￿9  XA-88 mAb). 
indicates that, in order to generate the negative signal resulting 
in inhibition of NK-mediated lysis, cross-linking of Kp43 
molecules (similar  to p58 molecules) is required. 
Individual NK Clones Can  Use More  Than  One  Type of 
Receptor  for MHC Class IMolecules.  As shown above (Table 
1), the clone ET34, displaying the EB6 +/GL183-  pheno- 
type, apparently functions as a typical group 1 clone (3) when 
analyzed against target cells expressing the appropriate, pro- 
tective HLA-C molecules (in this case the Cw4 + C1R cells). 
On the other hand, the ET34 clone also failed to kill the 
homozygous R6/12367 cell line (A3, B7, CwT) which does 
not express the protective HLA-C alleles recognized by clas- 
sical group 1 (EB6 +/GL183-) clones.  A possible  explana- 
tion of these data could be that other protective class I mole- 
cules could be expressed on the R6/12367 cell line. This is 
strongly suggested by the finding that lysis of the R6/12367 
cells mediated by the ET34 clone was induced by the anti- 
HLA class I mAb A6-136 (not shown) (20).  As shown in 
Fig.  6 a,  the cytolytic activity of clone ET34 against the 
Cw4 + C1R cell line occurred in the presence of anti-EB6 
mAbs (EB6 or XA-141 mAbs) but not of anti-Kp43 mAbs 
(XA-185 or XA-88 mAbs) (Fig. 6 A, left panel). On the con- 
trary, lysis of the HLA-B7 + R6/12367 cell line by the same 
clone was reconstituted by anti-Kp43 mAbs but not by anti- 
EB6 mAbs (Fig. 6 A, right panel). B7-transfected  C1R cells 
express both Cw4 and B7, i.e., the protective alleles indepen- 
dently expressed on untransfected C1R or R6/12367 target 
cells. Therefore, we analyzed the ability of anti-EB6 or anti- 
Kp43 mAbs to reconstitute the ET34-mediated lysis of these 
target cells. As shown in Fig. 6 B, the addition of either anti- 
EB6 or anti-Kp43 mAbs alone was not effective. However, 
reconstitution of lysis of C1R/B7 target cells occurred after 
the simultaneous addition of both mAbs. These data suggest 
that  a  simultaneous blocking of the  two Cw4/EB6  and 
B7/Kp43 receptor/ligand interactions is required to efficiently 
interfere with the protective signals delivered by the C1R/B7 
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Figure 6.  The ET34 NK clone express two distinct class I-specific func- 
tional receptors (p58 and Kp43). In A, clone ET34 (GL183-/EB6 +/Kp43 
bright) has been assessed for cytolytic activity against C1R (Cw4*) or 
R6/12367 (A3, B7, Cw7) target cells in the presence or in the absence 
of anti-p58 and anti-Kp43 mAbs. Target cell lysis in the presence of the 
anti-p58 mAbs EB6 (asterisk), or XA-141 (+) anti-Kp43 mAbs XA-185 
(e) or XA-88 (I)- (B) Assessment of the cytolytic activity of clone ET34 
against CIR/B7 target cells (Cw4 +, B7 +) in the presence or in the ab- 
sence of mAbs. Cytolysis in the presence of both anti-Kp43 and anti-p58 
mAbs ([~); of EB6 mAb ([]); of XA-185 mAb ([~) or in the absence 
of mAb (I). Right, a group 1 (GL183-/EB6 §  dull) NK clone 
(SE-456) is shown for comparison. 
cell line. The simultaneous blocking of both receptors was 
also required to allow killing of autologous B-EBV target 
cells by clone ET34 (not shown). Fig. 6 B, right panel, shows, 
for comparison, a  classical GL183-/EB6 + clone (SE456) 
tested against C1R/B7 target cells. It is evident that, in this 
case, the addition of an anti-EB6  mAb alone is sufficient to 
reconstitute target cell lysis. 
550  Human NK Cell Receptors for HLA-Class I Molecules Expression of Kp43 Molecules on NK Clones Belonging to 
Different GLI83/EB6 Phenotypic Groups.  The Kp43 mole- 
cule was previously described by the use of the HP3B1 mAb, 
as a surface dimer of •70  kD expressed on a fraction of TCR- 
3,//~ + lymphocytes and on virtually all IL-2-activated NK 
cells (21, 22). Although, in "resting" peripheral blood-derived 
CD16 § NK cell populations, Kp43 molecule was detectable 
only on a cell subset (variable in size among different indi- 
viduals), after culture in the presence of IL-2, it was acquired 
also by Kp43-negative cells.  Our analysis at the clonal level 
substantially confirms these results, since essentially all clones 
were Kp43 +. However, remarkable variations in intensity of 
Kp43 surface expression were detectable in different NK clones. 
Thus,  in  donor  E.  C.  all  the  GL183-/EB6-  NK  clones 
specific for HLA-B7 were brightly stained by anti-Kp43 mAbs 
(two representative clones, SE276 and SE192,  are shown in 
Fig. 7, A  and B). In contrast, in GL183 +/EB6 § clones, the 
intensity of expression of Kp43 molecules was low (Fig. 7, 
G-/).  In GL183-/EB6 + clones,  the expression was inter- 
mediate between  p58-negative  and  GL183 §  +  clones 
(Fig.  7, E  and F). 
Interestingly, different from the other 12 GL183-/EB6 + 
clones analyzed in detail, the ET34 clone was brightly stained 
by anti-Kp43 mAbs (thus it was similar to the B7-specific, 
p58-negative clones). As shown above, the ET34 clone was 
able to recognize both Cw4 and B7 alleles,  by two distinct 
inhibitory receptors. Another expression was represented by 
the p58-negative  SE200  clone.  Different  from  B7-specific 
clones, the SE200 clone expressed Kp43 molecules at inter- 
mediate levels.  It is of note that SE200 was representative 
of "~10% of the p58-negative NK clones able to lyse the 81 
cell line (see Fig. 1 and Table 1) as well as all cell transfectants 
analyzed (Table 2). Taken together these data suggest the ex- 
istence of a correlation between the levels of expression of 
Kp43 molecules and their usage as receptors for protective 
class I alleles. It is also evident that, in some NK clones, Kp43 
molecules may not be used as receptors involved in the gener- 
ation of inhibitory signals (when expressed at medium/low 
levels). 
Expression and Function of Kp43  Molecules in  Different 
Donors.  P58-negative clones were derived from two other 
donors (G. T. and L. N.) and analyzed for their HLA specificity 
and for the role of Kp43 molecules as receptors for MHC 
class  I. These clones were screened in a cytolytic assay for 
their ability to kill C1R/B7 or C1R/B27 cell lines. Although 
not shown, ,x,45% ofp58-negative clones derived from donor 
L.  N.  and 35%  derived from donor G.  T. were unable to 
lyse C1R/B7 target cells.  Representative B7-specific clones 
from these two donors are shown in Fig. 8 (A, B, E, F, and 
H). In addition, a small fraction of clones displayed a pattern 
of reactivity different from B7-specific clones. Thus, clones 
LN35 and LN36 (from donor L. N.) (Fig. 8, C and D) and 
GT25 and GT40 (from donor G. T.) lysed C1R/BT, but not 
C1R/B27  target cells.  In addition, clone GT20 (Fig. 8 G) 
did not kill either C1R/B7 or C1R/B27 target cells, but lysed 
untransfected C1R cells. The cytolytic activity of B7-specific 
clones from donors L.  N.  or G. T. was efficiently restored 
by anti-Kp43 mAbs when tested against BT-protected target 
cells. In Fig. 8, A and B, two representative BT-specific clones 
isolated from donor L. N. (LN5 and LN6) are analyzed for 
the cytolytic activity against C1R, C1R/B7, and C1R/B27 
target cells.  Both C1R and C1R/B27 cells were efficiently 
lysed, whereas C1R/B7 target cells were not (lysis of C1R/B7 
occurred only in the presence of anti-Kp43 mAbs). A similar 
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Figure 7.  Expression  of Kp43 molecules  in different 
phenotypic groups of NK clones. Three distinct groups 
of clones were identified on the basis of the surface 
expression of Kp43. In A, B, and C, three representa- 
tive B7-specific, Kp43 bright, NK clones are shown 
(SE-276; SE-192, and ET-34), respectively. In D, E, 
and F, clones with "medium" Kp43 fluorescence are 
shown. In D, the SE-200 clone (p58-negative) of un- 
determined specificity  is shown. In E and F clones SE- 
273 and SE-456 (GL183-/EB6 +  ) belonging to group 
1 clones are shown. In panels G,  H,  and I,  three 
GL183 +/EB6 + clones (SE-362, SE-133, and SE-204) 
with low Kp43  fluorescence are shown. 
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Figure 8.  A  fraction of  p58- 
negative NK clones is specific for 
HLA-B27.  Representative p58- 
negative  clones  isolated  from  donors 
G. T. and L. N. are shown. Clones 
were analyzed  for cytolytic  activity 
against the following  target cells: 
(a) untransfected  C1R cells  (11); (b) 
CIR/B7 cells  either  in the absence 
(~) or in the presence (D) of the 
(anti-Kp43)  XA-185 mAb;  (c) 
CIR/B27 cells  either  in the absence 
([]) or in the presence (1~) of the 
same mAbs. In A-D, clones from 
donor L. N., LN5 and LN6 are 
specific for  B7,  whereas clones 
LN35 and LN36 are specific for 
B27. In E-H,  clones from donor 
G. T., GT1, GT65, and GT21 are 
specific  for B7, clone  GT20 display 
an unique  pattern as it fails  to lyse 
both CIR/B7 and CIR/B27. 
pattern of cytolysis, was detectable also in three representa- 
tive B7-specific clones (GT1, GT65, and GT21) derived from 
donor G. T. (Fig.  8, E, F, and H). On the other hand, in 
the case of the two p58-negative B27-specific clones (LN35 
and LN36), anti-Kp43 mAbs did not restore lysis of C1R/B27 
target cells (Fig. 8, C and D). These data suggest that recog- 
nition of HLA-B27 allele is not mediated by Kp43 molecules 
and that a different receptor may be involved. Along this line, 
the  NK  clone  GT20  (unable  to  kill  both  C1R/B7  and 
C1R/B27), in the presence of anti-Kp43 mAb, lysed C1R/B7 
targets, but not CIK/B27 (Fig. 8 G). A possible explanation 
could be that clone GT20, similar to clone ET34, is equipped 
with two distinct receptors for MHC molecules:  one, repre- 
sented by Kp43, involved in the recognition of B7 and an- 
other, still undefined, (Kp43-1ike?) involved in the recogni- 
tion  of B27.  It  is  noteworthy that  lysis of CIR/B27 by 
B27-specific clones, including GT20, was reconstituted in the 
presence  of anti-class  I mAbs (not shown). 
Analysis of the expression  of Kp43 molecules on a series 
of NK clones derived from G. T. and L. N. donors revealed 
that B7-specific clones expressed high levels of Kp43 mole- 
cules,  whereas B27-specific clones  and clones of undefined 
specificity expressed intermediate/low levels of Kp43 surface 
molecules (not shown). 
Discussion 
In the present study we provide evidence for the existence 
of an additional NK receptor for HLA class I molecules. This 
receptor has been identified with the Kp43 molecule (21, 22) 
and is distinct from the formerly identified p58 molecules 
(18,  19). Whereas p58  molecules function as receptors  for 
552  Human  NK Cell Receptors for HLA-Class I Molecules HLA-C alleles (15), the Kp43 molecules function as receptors 
for (at least some) HLA-B alleles. In addition,  evidence is 
provided that single NK clones can be equipped with more 
than one type of receptor for HLA class I. 
As  previously shown,  the  protective effect of HLA-C 
molecules on target cells was reversed by anticlass  I (20) or 
anti-p58 mAbs (15). This indicates that masking the receptor 
molecules or their ligands was sufficient to reconstitute the 
cytolytic activity of NK clones. However, a fraction of NK 
clones, did not express surface p58 receptors (recognized by 
GL183 or EB6 mAbs) (19). This NK subset was operation- 
ally defined as p58-negative and their specificity for MHC 
molecules was still undefined. Now we show that (at least 
in the three donors analyzed) a fraction of NK clones dis- 
playing the p58-negative phenotype recognize and is inhibited 
by HLA-B7 molecules. This HLA-B specificity is not limited 
to a single HLA-B allele as indicated by the finding that HLA- 
B8 and HLA-B14 also mediated target cell protection from 
HLA-B7-specific NK clones. On the other hand, the HLA- 
B27 allele did not exert a protective effect from these clones. 
Although an extensive genetic analysis of the protective class 
I alleles, paralleled by the study of a large panel of HLA-B 
transfectants, would be required,  these data suggest that, 
similar to HLA-C-specific groups of NK clones (3, 15), also 
HLA-B-specific  NK  clones  recognize  distinct  groups  of 
HLA-B alleles. Screening of mAbs for the ability to reconsti- 
tute lysis of HLA-B7-protected target cells by p58-negative 
NK clones led to the isolation of two new mAbs.  Impor- 
tantly, both mAbs were directed to Kp43 molecules. These 
mAbs were analyzed on a set of representative clones dis- 
playing specificity for HLA-B7.  In all instances,  anti-Kp43 
mAbs or their F(ab')2 fragments reconstituted the cytolytic 
activity against HLA-B7 § target cells. Similar results were 
obtained by using, as target cells, CIR cells transfected with 
HLA-B8 or B14 or an autologous HLA-B14 + B-EBV cell 
line. On the other hand, anti-Kp43 mAbs did not reconsti- 
tute  the cytolytic activity of NK  clones displaying other 
specificities. For example, the lysis mediated by HLA-C-spe- 
cific  NK  clones  (p58 +)  against  HLA-C-protected  target 
cells was modified (i.e., reconstituted) by anti-p58 mAbs but 
not by anti-Kp43 mAbs. This indicates that, although these 
molecules are expressed also by p58 § clones, they are not in- 
volved in recognition of HLA-C molecules. Interestingly, un- 
like  most  p58+/Kp43 +  clones  analyzed,  a  single  clone 
(ET34) has been identified, and analyzed in detail, in which 
both  p58  and  Kp43  molecules  functioned  as  inhibitory 
receptors. This done, similar to the previously identified group 
1 clones (3), expressed the GL183-/EB6 + phenotype, did 
not kill target cells expressing Cw4, and its cytolytic activity 
against CIR target cells (Cw4 +) was reconstituted by anti- 
EB6 mAbs (15). However, this clone also failed to kill target 
cells lacking Cw4 or related protective alleles. For example, 
the ET34 clone did not kill homozygous cell lines displaying 
the A3, B7,  Cw7, MHC haplotype. In this case, anti-p58 
mAbs did not reconstitute the cytolytic activity. However, 
reconstitution of cytolytic activity was obtained by anti-Kp43 
mAbs.  Thus,  the cytolytic activity (i.e.,  the specificity) of 
ET34 clone appears  to be controlled by two distinct types 
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of receptors for MHC class I molecules (i.e., the EB6 mole- 
cules specific for the Cw4 allele and the Kp43 molecules specific 
for the HLA-B7 allele).  As a consequence, when analyzed 
on target cells expressing both protective alleles (such as the 
CIR/B7 cell line), the combined use of both antireceptor 
mAbs as required in order to reconstitute the cytolytic ac- 
tivity of the ET34 clone. 
Our studies indicate that a different subset of p58-negative 
NK clones recognize a different HLA-B allele, namely the 
HLA-B27. In this case, however, Kp43 molecules were not 
involved in the recognition of the B27 allele as indicated by 
the failure of anti-Kp43 mAbs to reconstitute the cytolytic 
activity of these clones. Along this line,  anti-Kp43  mAbs 
could reconstitute the cytolytic activity of another p58-negative 
clone (GT20) specific for both B7 and B27 alleles, only when 
tested against CIR/B7 but not C1R/B27 target cells. These 
data are compatible with the existence, on clone GT20, of 
another receptor specific for the B27 allele. In p58 § clones, 
a precise correlation has been established between the HLA-C 
alleles recognized and their p58 phenotype (3, 5, 13-15,  19). 
In the case of clones specific for HLA-B molecules, a similar 
correlation between the HLA-B alleles recognized and the 
Kp43  surface phenotype could not be established.  Indeed, 
essentially all  cloned NK cells expressed Kp43  molecules. 
Nevertheless,  differences could be  detected in  the relative 
fluorescence intensity of different NK clones. Remarkably, 
clones recognizing HLA-B7 were consistently brightly stained 
by anti-Kp43 mAbs. On the contrary, the HLA-B27-specific 
p58-negative clones as well as most clones coexpressing p58 
and Kp43 receptors were characterized by a medium/low Kp43 
fluorescence. A possible explanation of these observations could 
be that the number of interactions between HLA-B7 and Kp43 
receptor molecules may be critical for the induction of the 
negative signal necessary to induce the protective effect. If 
this hypothesis is correct, NK clones expressing a relatively 
low number of Kp43  molecules may not be able to reach 
the critical number of interactions with the protective MHC 
molecules required to deliver an effective negative signal. Thus, 
negative signaling via Kp43 may not be required in clones 
that already express other types of functional receptors as it 
occurs  in  p58 §  NK  clones  that  are already inhibited  by 
HLA-C molecules (a remarkable exception is represented by 
the ET34 clone). As suggested by studies of Storkus et al. 
(25),  also HLA-A-specific NK cells appear to exist. Thus, 
it is possible  that a fraction of p58-negative NK clones may 
express a still undefined negative receptor specific for HLA-A 
alleles. 
Our data suggest that NK clones which express  a given 
receptor type (e.g., p58 molecules) in general, express low 
amounts of Kp43 molecules. On the other hand, Kp43  is 
brightly expressed in a significant fraction of p58-negative 
NK cells. In addition, as revealed by the functional behavior 
of the ET34 and GT20 clones, also NK cells exist which ex- 
press two distinct inhibitory receptors represented by Kp43 
and p58  molecules (ET34  clone),  or by Kp43  and a  still 
undefined receptor for HLA-B27 (GT20 clone). The relative 
frequency of these clones remains to be established. It is evi- 
dent that,  a NK cell equipped with two different negative receptors will lyse target cells expressing two relevant class 
I alleles (e.g., autologous cells) only when both class I alleles 
are simultaneously masked (or downregulated) (20). Another 
possible explanation should be considered to explain the func- 
tional  differences  between  NK  cells  expressing  high  v. 
medium/low  amounts  of Kp43  surface  molecules.  It  is 
noteworthy that, in Kp43 "bright" clones, we could consis- 
tently detect: (a) The specificity for certain HLA-B alleles; 
(b) the reconstitution  of the cytolytic activity against pro- 
tected target  cell by nti-Kp43  mAbs and (c) the inhibition 
of lysis (of Fcq,  R + target cells) in redirected killing assays. 
On the contrary, in Kp43 medium/low clones, Kp43 mole- 
cules did not appear to participate in the mechanisms of pro- 
tection consequent to recognition of HLA-B alleles. A pos- 
sible interpretation  of these data would be that  the Kp43 
antigen may include homologous,  though  structurally dis- 
tinct,  molecules that could confer different specificities  for 
HLA molecules. Molecular cloning of the Kp43 molecule- 
encoding gene(s) will allow exploration of this possible struc- 
tural heterogeneity. Along this line,  recent data would sug- 
gest that, in some instances,  polyclonal NK cell populations 
may contain cells that  are triggered,  rather  than inhibited, 
by anti-Kp43  mAbs (Lopez-Botet,  M., unpublished obser- 
vations). Isolation and functional analysis of NK clones dis- 
playing this property should help to better understand these 
data. If, also in this case, anti-Kp43 mAbs mimick the func- 
tional effect of the Kp43/class I interaction, it is evident that 
this interaction would lead to a "positive" signal and to trig- 
gering rather  than inhibition  of cytolytic activity. In addi- 
tion, it will be of interest to define whether these NK clones, 
different from those inhibited by the interaction with HLA- 
B7, express  medium-low levels of Kp43 surface molecules. 
In conclusion, distinct NK cells are capable of recognizing 
different class I molecules. This occurs via defined receptor 
structures.  While p58 receptors mediate recognition of HLA-C 
molecules, Kp43 receptors are involved in recognition of (at 
least one) HLA-B alleles. Since we recently showed that all 
clonogenic NK cells recognize class  I molecules (20),  it is 
predictable that NK clones which do not belong to the HLA-C 
or HLA-B allele-specificity defined so far, may be specific for 
different groups of HLA-A or B alleles. These cells may be 
equipped with a still undefined third type of receptor or with 
receptors belonging to either the p58 or the Kp43 molecular 
family, but not reactive with the available mAbs. The finding 
that single NK cells may also express two different types of 
receptors, displaying different class I specificities, suggest that 
the NK cell repertoire for MHC may be influenced not only 
by the expression of different receptors, but also by the coex- 
pression of a different  second receptor. 
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